Richard H. Fink
Ask VT AI
View News Summary
- Palantir raises annual revenue forecast amid strong AI demand, positioning it as a leader in data analytics and software industry.
- Trump DOJ seeks dismissal of lawsuit challenging FDA's approval of abortion pill mifepristone, citing procedural issues rather than merits of the drug's approval.
- Trump signs executive actions to boost domestic drug manufacturing and oversight of gain-of-function research, raising concerns over potential higher costs and shortages.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Palantir raises annual revenue forecast amid strong AI demand, positioning it as a leader in data analytics and software industry.
- Trump DOJ seeks dismissal of lawsuit challenging FDA's approval of abortion pill mifepristone, citing procedural issues rather than merits of the drug's approval.
- Trump signs executive actions to boost domestic drug manufacturing and oversight of gain-of-function research, raising concerns over potential higher costs and shortages.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Richard H. Fink
News from Richard H. Fink